United States · Cambridge, MA, USA · North America
Biotechnology · DeepTech · Health
Beam Therapeutics is a biotechnology company engaged in creating genetic medicines based on its base editing technology. Beam is pioneering the use of base editing, a potential new class of precision genetic medicines, with a vision of providing life-long cures to patients suffering from serious diseases. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.Something looks off?